FeesSafety
Pluang+

NB Private Equity Partners buys back 49,489 Class A shares, reducing outstanding shares to 35.95 million.

Company Fundamentals
13 Nov 2026, 11:31 WIB
Globe News Wire
View Source
Neutral
NB Private Equity Partners buys back 49,489 Class A shares, reducing outstanding shares to 35.95 million.

Neuberger Private Equity Partners Limited repurchased 49,489 Class A shares on November 12, 2026, at prices between £15.40 and £15.52 per share. These shares will be cancelled, lowering the total outstanding Class A shares to 35,952,059. The company holds an additional 3,150,408 Class A shares in treasury. This buyback is part of a shareholder-approved program aimed at managing the company's capital structure and potentially enhancing shareholder value.

Neuberger Private Equity Partners Limited's share buyback reduces outstanding Class A shares to 35,952,059. For readers following the Financials sector, here is Pluang's market snapshot as of Nov 13, 2026 15:11 WIB: out of 142 priced US Financial stocks, 44 rose and 96 fell. Notable movers include Coinbase Global, Inc. (COIN) at USD 127.09 with a 1-day change of -2.74% and a typical hold time on Pluang of 81 days, Banco Santander SA (SAN) at USD 12.14 down 2.72%, and Sumitomo Mitsui Financial Group Inc (SMFG) at USD 25.00 up 2.59% with 100% buy order activity on Pluang.

More News

China Eastern Airlines signs $540M procurement deals, unveils new aviation tech at CIIE

China Eastern Airlines signs $540M procurement deals, unveils new aviation tech at CIIE

China Eastern Airlines signed 23 procurement agreements worth $540 million with 15 suppliers from eight countries at the 9th China International Import Expo in Shanghai. The deals cover aircraft engines, aviation materials, jet fuel, and in-flight ca...

Bullish
1 hour ago
PAS-004 shows strong reductions in neurofibroma size with good safety, advancing to Phase 2 trials after FDA clearance.

PAS-004 shows strong reductions in neurofibroma size with good safety, advancing to Phase 2 trials after FDA clearance.

Pasithea Therapeutics announced positive Phase 1/1b results for PAS-004, showing significant reductions in cutaneous neurofibromas (cNF) size by up to 71% with continued treatment and early activity in plexiform neurofibromas (PN). The drug demonstra...

Company Fundamentals
Bullish
3 hours ago
Eramet launches €500M share capital increase with preferential subscription rights to reduce debt.

Eramet launches €500M share capital increase with preferential subscription rights to reduce debt.

Eramet announced a €500 million share capital increase through a rights issue, offering 6 new shares for every 5 existing shares at €14.49 each. The proceeds will be used to reduce the company's debt and strengthen its balance sheet as part of a prev...

Company Fundamentals
Neutral
3 hours ago
Shandong-South Korea Economic Conference opens with 23 new cooperation projects signed in Yantai.

Shandong-South Korea Economic Conference opens with 23 new cooperation projects signed in Yantai.

The 9th Shandong-South Korea Economic and Trade Cooperation Conference and Yantai South Korea Week began on November 6 in Yantai, Shandong Province, highlighting strong economic ties between Shandong and South Korea. Over 150 enterprises participated...

Bullish
4 hours ago
Bitcoin dips below $68,000 amid $1.5B crypto liquidations and ETF outflows, facing risk of further decline to $65,000.

Bitcoin dips below $68,000 amid $1.5B crypto liquidations and ETF outflows, facing risk of further decline to $65,000.

Bitcoin briefly fell below $68,000 on November 13, driven by accelerated selling and leveraged liquidations nearing $1.5 billion, mainly from long positions. Institutional demand weakened as Bitcoin ETFs saw nearly $1.5 billion in net outflows over a...

Bearish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App